688271.SHG Shanghai United Imaging Healthcare Co. Ltd. A
- Market cap
- CNY 96.9B
- P/E
- 54.2x
- P/B
- 4.40x
- ROE
- 6.3%
- Dividend yield
- 0.18%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 688271.SHG undervalued?
Graham numberThe Graham number of Shanghai United Imaging Healthcare Co. Ltd. A cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shanghai United Imaging Healthcare Co. Ltd. A fundamental analysis
No fundamental analysis for Shanghai United Imaging Healthcare Co. Ltd. A yet.
Shanghai United Imaging Healthcare Co. Ltd. A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shanghai United Imaging Healthcare Co. Ltd. A
Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company provides molecular imaging products; and magnetic resonance imaging solutions. It also offers computed tomography equipment; digital radiography equipment; mammography equipment; angiography equipment; mobile C-arm equipment; and radi…
Full company profileShanghai United Imaging Healthcare Co. Ltd. A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shanghai United Imaging Healthcare Co. Ltd. A annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 5.76B | 7.25B | 9.24B | 11.4B | 10.3B | 13.8B | 14.1B |
| Gross Profit | 2.80B | 3.59B | 4.47B | 5.37B | 5.00B | 6.49B | 6.52B |
| Operating Income | 1.20B | 1.66B | 1.96B | 1.99B | 1.25B | 2.12B | 1.82B |
| EBITDA | - | - | 2.20B | 2.49B | 1.77B | 2.54B | 1.52B |
| Net Income | 903M | 1.42B | 1.66B | 1.97B | 1.26B | 1.87B | 1.38B |
| EPS | 1.25 | 1.96 | 2.01 | 2.40 | 1.53 | 2.27 | 1.67 |
| Balance Sheet | |||||||
| Total Assets | 9.66B | 10.4B | 24.2B | 25.3B | 28.0B | 32.8B | 36.8B |
| Total Liabilities | 6.05B | 5.33B | 6.73B | 6.45B | 8.13B | 11.2B | 14.8B |
| Shareholders' Equity | 3.60B | 5.04B | 17.5B | 18.9B | 19.9B | 21.6B | 22.1B |
| Cash & Short-term Investments | 3.20B | 2.92B | 10.1B | 7.58B | 8.40B | 5.50B | 3.14B |
| Cash Flow | |||||||
| Operating Cash Flow | 3.31B | 942M | 683M | 133M | -619M | 2.68B | - |
| Capital Expenditure | 703M | 347M | 741M | 1.08B | 1.95B | 2.09B | 2.56B |
| Free Cash Flow | 2.61B | 596M | -58.5M | -943M | -2.56B | 586M | -2.98B |
| Ratios | |||||||
| ROE | 25.1% | 28.1% | 9.5% | 10.5% | 6.3% | 8.7% | 6.3% |
| ROA | 9.3% | 13.7% | 6.8% | 7.8% | 4.5% | 5.7% | 3.7% |
| Net Profit Margin | 15.7% | 19.5% | 17.9% | 17.3% | 12.3% | 13.5% | 9.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Shanghai United Imaging Healthcare Co. Ltd. A dividends
- Dividend yield
- 0.18%
- Forward dividend
- 0.26 CNY
- Payout ratio
- 9.4%
- Ex-dividend date
- Sep 9, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 176M | 0.21 | 9.4% |
| 2024 | CNY 304M | 0.37 | 24.1% |
| 2023 | CNY 166M | 0.20 | 8.4% |
| 2022 | CNY 957K | 0.00 | 0.1% |
| 2021 | CNY 8.11M | 0.01 | 0.6% |
| 2020 | CNY 56.7M | 0.08 | 6.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Shanghai United Imaging Healthcare Co. Ltd. A
- Insiders 56.59%
- Institutions 9.74%
- Public & others 33.67%
- Shares outstanding 824M
- Free float 388M
Shanghai United Imaging Healthcare Co. Ltd. A company profile
- Company name
- Shanghai United Imaging Healthcare Co. Ltd. A
- Ticker
- 688271.SHG
- ISIN
- CNE100005PN5
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 8,703
- Fiscal year end
- December
- Address
- 2258 Chengbei Road, Shanghai, China, 201807
- Phone
- 86 21 6707 6888
- Website
- united-imaging.com
About Shanghai United Imaging Healthcare Co. Ltd. A
Shanghai United Imaging Healthcare Co., Ltd. engages in the provision, development, and production of advanced medical imaging solutions, radiotherapy equipment, life science instruments, and intelligent digital solutions worldwide. The company provides molecular imaging products; and magnetic resonance imaging solutions. It also offers computed tomography equipment; digital radiography equipment; mammography equipment; angiography equipment; mobile C-arm equipment; and radiotherapy systems comprising uRT-linac 506c, uRT-linac 306, and Intelligent RT Cloud Ecosystem. In addition, it provides uVision, a remote vision system that enables real-time positioning observation and automatic field of view identification; a low-dose, 3D mammography platform; and Remote Vision and Exposure Control technology application, a handheld X-ray from UIH that enables accurate positioning while reducing exposure radiation. Further, the company offers United Neuro, a medical imaging software used to analyze functional magnetic resonance imaging and diffusion tensor imaging data, and U-VIEWER, software that helps in viewing DICOM images. Additionally, it provides training, monitoring, maintenance, and troubleshooting services. Shanghai United Imaging Healthcare Co., Ltd. was founded in 2011 and is headquartered in Shanghai, China.
Shanghai United Imaging Healthcare Co. Ltd. A management
10- Mr. Zhang QiangChairman & Co-CEO · born 1969
- Mr. Shengtan GuoGM, Co-CEO & Director · born 1963
- Mr. Bao JunPresident & Director · born 1965
- Mr. Jian Bao WangCFO & Head of Finance · born 1984
- Mr. Cai TaoBoard Secretary, Chief Investment Officer & Director · born 1972
- Mr. Hongdi LiSenior VP, CTO & Core Technician · born 1967
- Mr. Fengua XiaSenior Vice President · born 1970
- Ms. Yeheng YuSenior Vice President · born 1979
- Mr. Hong MiaoSenior Vice President · born 1972
- Mr. Yunlei LvVice President · born 1978